Insights

Innovative Antimicrobial Solutions Akeso Biomedical is developing broad-spectrum compounds, Fe3C, aimed at treating bacterial infections and microbial biofilms, presenting opportunities to introduce advanced antimicrobial products across healthcare, agricultural, and food safety sectors.

Food Safety Focus The company's lead product prevents food poisoning caused by Campylobacter, a major concern for food production and processing companies, indicating a strong potential market for food safety solutions in the poultry industry and beyond.

Partnership Opportunities Recent collaborations with Banham Poultry highlight opportunities to expand partnerships with poultry producers, food suppliers, and agricultural firms seeking innovative methods to reduce bacterial contamination and improve product safety.

Funding and Growth Potential With recent financing of $4.4M and partnerships, Akeso Biomedical shows growth momentum, presenting a sales opportunity to engage with biotech investors and companies interested in infectious disease solutions and biofilm management.

Market Entry Strategies Targeting early stage biotech and food safety markets, companies in related sectors such as animal health, food processing, and antimicrobial technology could serve as strategic partners or customers to accelerate product adoption.

Akeso Biomedical, Inc. Tech Stack

Akeso Biomedical, Inc. uses 8 technology products and services including iCIMS, Google Workspace, Google Tag Manager, and more. Explore Akeso Biomedical, Inc.'s tech stack below.

  • iCIMS
    Applicant Tracking Systems
  • Google Workspace
    Email
  • Google Tag Manager
    Tag Management
  • Google Search Console
    Web Analytics
  • Piwik PRO Core
    Web Analytics
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers
  • Apache
    Web Servers

Akeso Biomedical, Inc.'s Email Address Formats

Akeso Biomedical, Inc. uses at least 1 format(s):
Akeso Biomedical, Inc. Email FormatsExamplePercentage
FLast@akesobiomedical.comJDoe@akesobiomedical.com
80%
First.Last@akesobiomedical.comJohn.Doe@akesobiomedical.com
20%

Frequently Asked Questions

Where is Akeso Biomedical, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc.'s main headquarters is located at 850 Winter Street Waltham, Massachusetts 02451 United States. The company has employees across 1 continents, including North America.

What is Akeso Biomedical, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Akeso Biomedical, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Akeso Biomedical, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc.'s official website is akesobiomedical.com and has social profiles on LinkedInCrunchbase.

What is Akeso Biomedical, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Akeso Biomedical, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Akeso Biomedical, Inc. has approximately 2 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. W.. Explore Akeso Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Akeso Biomedical, Inc. belong to?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc. operates in the Biotechnology Research industry.

What technology does Akeso Biomedical, Inc. use?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc.'s tech stack includes iCIMSGoogle WorkspaceGoogle Tag ManagerGoogle Search ConsolePiwik PRO CoreGoogle AnalyticsNginxApache.

What is Akeso Biomedical, Inc.'s email format?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc.'s email format typically follows the pattern of FLast@akesobiomedical.com. Find more Akeso Biomedical, Inc. email formats with LeadIQ.

How much funding has Akeso Biomedical, Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2026, Akeso Biomedical, Inc. has raised $574K in funding. The last funding round occurred on Feb 12, 2021 for $574K.

When was Akeso Biomedical, Inc. founded?

Minus sign iconPlus sign icon
Akeso Biomedical, Inc. was founded in 2014.

Akeso Biomedical, Inc.

Biotechnology ResearchMassachusetts, United States2-10 Employees

Akeso Biomedical, Inc., based in Waltham, Massachusetts, is a small, early-stage biotechnology company focused on developing new solutions for bacterial infections, microbial biofilms, and chronic wounds. It is pursuing a novel class of antimicrobial compounds labeled Fe3C, which aim to exhibit broad-spectrum activity against bacteria, along with a silk-based biomaterial technology licensed from Tufts University. 

The company’s lead product is a feed additive intended to prevent Campylobacter-related food poisoning in poultry. Campylobacter causes more cases of foodborne illness in the EU than Salmonella, E. coli, and Listeria combined, with approximately 280,000 UK cases and 1.3 million cases in the US each year. In 2017 Akeso announced a partnership with Banham Poultry to explore reducing Campylobacter in poultry using its Fe3C technology.

Section iconCompany Overview

Headquarters
850 Winter Street Waltham, Massachusetts 02451 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $574K

    Akeso Biomedical, Inc. has raised a total of $574K of funding over 5 rounds. Their latest funding round was raised on Feb 12, 2021 in the amount of $574K.

  • $1M

    Akeso Biomedical, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $574K

    Akeso Biomedical, Inc. has raised a total of $574K of funding over 5 rounds. Their latest funding round was raised on Feb 12, 2021 in the amount of $574K.

  • $1M

    Akeso Biomedical, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.